What Are the Third-Line Treatments for Severe PSC Itching?

When first-line treatments like cholestyramine and second-line treatments like rifampin do not provide adequate relief from the intense itch (pruritus) of Primary Sclerosing Cholangitis (PSC), you still have options. According to major liver disease guidelines, the third-line defense is an oral opioid antagonist like naltrexone, and the fourth-line option is an SSRI like sertraline ^[1][2]. Your doctor will also likely investigate if a specific physical blockage in your bile ducts is making the itching worse, which can be treated with a targeted endoscopic procedure ^[3].

Because severe pruritus can dramatically impact your sleep, mental health, and overall quality of life, finding an effective treatment is a top clinical priority ^[4]. Here is what you need to know about the next steps on the treatment ladder and how they might help you.

Third-Line Therapy: Oral Opioid Antagonists

When bile acids build up in the body due to liver disease, they can inadvertently trigger the body’s natural opioid receptors, causing the brain to register a sensation of extreme, unyielding itching. Opioid antagonists are medications that block these receptors, preventing the itch signal from reaching the brain.

• Naltrexone: This is the most common third-line medication ^[5]. Because it blocks opioid receptors, starting naltrexone can cause opioid withdrawal-like symptoms—such as nausea, abdominal pain, and mood changes—even if you have never taken opioid drugs. To prevent this, doctors typically start you on a very low dose and gradually increase it over time. It can take several weeks of this gradual dose increase to see a meaningful reduction in itching.
• Safety warning (Opioids): Naltrexone absolutely cannot be used if you are currently taking prescription opioid pain medications, as it will block their pain-relieving effects and trigger immediate withdrawal ^[6].
• Safety warning (Liver Health): While generally safe for many liver patients, naltrexone requires careful monitoring by a hepatologist, as it can carry a risk of liver toxicity and is generally contraindicated for patients who have progressed to acute liver failure or decompensated cirrhosis ^[7].

Fourth-Line Therapy: SSRIs

If naltrexone fails or cannot be tolerated, guidelines recommend moving to the fourth tier of the treatment ladder ^[2].

• Sertraline (Zoloft): This medication is a Selective Serotonin Reuptake Inhibitor (SSRI), a class of drugs typically used to treat depression and anxiety. However, at certain moderate doses, it has been shown to alter the brain’s perception of itching ^[8]. Like naltrexone, it may take a few weeks to reach its full anti-itch effect.
• Side Effects: While helpful for itching, SSRIs can cause common side effects such as initial nausea, insomnia, gastrointestinal issues, or sexual dysfunction ^[8].

Checking for Dominant Strictures (ERCP)

In PSC, ongoing inflammation causes scar tissue that narrows the bile ducts. Sometimes, one specific area becomes extremely narrow, forming what is called a dominant stricture. This severe blockage can cause a sudden, intense worsening of itching.

If your itching becomes intractable, your doctor may recommend an ERCP (Endoscopic Retrograde Cholangiopancreatography) ^[3]. During this procedure, a doctor inserts a flexible tube down your throat to your bile ducts and uses a tiny balloon to stretch the narrowed duct open, a process called endoscopic balloon dilation ^[9]. Opening a dominant stricture can significantly relieve symptoms ^[10].

• Understanding the Risks: While highly effective at opening strictures, ERCP is an invasive procedure with well-documented risks. The most significant complications are post-ERCP pancreatitis (inflammation of the pancreas) and cholangitis (infection of the bile ducts) ^[11][12]. You and your doctor must carefully weigh these risks against the severity of your symptoms.

Off-Label and Experimental Therapies

If the standard medical ladder does not provide relief, hepatologists may explore other evidence-based or experimental options. If you are interested in these, ask your hepatologist whether they can be prescribed “off-label” at your standard pharmacy or if you might qualify for an ongoing clinical trial.

• Fibrates: Medications like bezafibrate, originally designed to lower cholesterol, have been shown in clinical trials to be highly effective at improving moderate to severe pruritus in PSC patients ^[13][14].
• IBAT Inhibitors: These are newer, experimental therapies for PSC that block the reabsorption of bile acids in the intestines. Drugs like maralixibat have been shown to reduce serum bile acids and significantly improve severe itching in clinical trials for PSC ^[15][16].
• PPAR Agonists: Medications like seladelpar and elafibranor have recently been approved for other chronic liver diseases and are currently being investigated for PSC, showing strong promise in reducing itch ^[17][18].

Extracorporeal Liver Support and Transplant

In the rarest and most severe cases, where relentless itching cannot be controlled by any medication or procedure and becomes completely intolerable, doctors may consider “last resort” options.

These include extracorporeal liver support therapies, which use specialized dialysis-like machines (such as MARS or plasmapheresis) to physically filter toxins and bile acids directly out of your blood ^[19][20].

Ultimately, intolerable, refractory pruritus that responds to nothing else is a recognized indication for evaluating a patient for a liver transplant ^[21]. It is important to know that a transplant evaluation is a complex, multi-factor process that considers your overall liver function, MELD score, and physical health, not just the presence of severe itch.